A Phase 1b Study of Imvotamab in Severe Systemic Lupus Erythematosus
Conditions: Systemic Lupus Erythematosus; Lupus Erythematosus Intervention: Drug: Imvotamab Sponsor: IGM Biosciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2023 Category: Research Source Type: clinical trials
Descartes-08 for Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE) Intervention: Drug: Descartes-08 Sponsor: Cartesian Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials